US 12,453,752 B2
Hevamine-related plant compositions and methods
Michael Powell, Douglasville, GA (US); and Erick Vidjin' Agnih Gbodossou, Dakar-Etoile (SN)
Assigned to MOREHOUSE SCHOOL OF MEDICINE, Atlanta, GA (US)
Filed by MOREHOUSE SCHOOL OF MEDICINE, Atlanta, GA (US)
Filed on Apr. 27, 2022, as Appl. No. 17/660,967.
Claims priority of provisional application 63/208,698, filed on Jun. 9, 2021.
Prior Publication US 2022/0395548 A1, Dec. 15, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 36/42 (2006.01); A01N 63/50 (2020.01); A01P 1/00 (2006.01); A61K 31/352 (2006.01); A61K 33/30 (2006.01); A61K 38/47 (2006.01); A61P 31/18 (2006.01); C12N 15/10 (2006.01); C12N 15/82 (2006.01); C12P 19/34 (2006.01)
CPC A61K 36/42 (2013.01) [A01N 63/50 (2020.01); A01P 1/00 (2021.08); A61K 31/352 (2013.01); A61K 33/30 (2013.01); A61K 38/47 (2013.01); A61P 31/18 (2018.01); C12N 15/1096 (2013.01); C12N 15/8283 (2013.01); C12P 19/34 (2013.01); C07K 2319/01 (2013.01)] 12 Claims
OG exemplary drawing
 
1. A composition comprising:
an isolated/purified protein comprising an amino acid sequence at least 95% identical to SEQ ID NO: 4.